191 related articles for article (PubMed ID: 32466590)
1. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
[TBL] [Abstract][Full Text] [Related]
2. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
[TBL] [Abstract][Full Text] [Related]
3. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks.
Mathias B; O'Leary D; Saucier N; Ahmad F; White LS; Russell L; Shinawi M; Smith MJ; Abraham RS; Cooper MA; Kitcharoensakkul M; Green AM; Bednarski JJ
J Allergy Clin Immunol; 2024 Apr; 153(4):1113-1124.e7. PubMed ID: 38065233
[TBL] [Abstract][Full Text] [Related]
4. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A
Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review.
Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625
[TBL] [Abstract][Full Text] [Related]
6. MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.
Wilms C; Kroeger CM; Hainzl AV; Banik I; Bruno C; Krikki I; Farsam V; Wlaschek M; Gatzka MV
Oncotarget; 2017 Sep; 8(40):67287-67299. PubMed ID: 28978033
[TBL] [Abstract][Full Text] [Related]
7. 2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs.
Wilms C; Krikki I; Hainzl A; Kilo S; Alupei M; Makrantonaki E; Wagner M; Kroeger CM; Brinker TJ; Gatzka M
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495602
[TBL] [Abstract][Full Text] [Related]
8. Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1.
Li N; Xu Y; Yu T; Yao R; Chen J; Luo C; Wang J
Gene; 2020 Oct; 757():144938. PubMed ID: 32640305
[TBL] [Abstract][Full Text] [Related]
9. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
[TBL] [Abstract][Full Text] [Related]
11. The histone H2A deubiquitinase USP16 interacts with HERC2 and fine-tunes cellular response to DNA damage.
Zhang Z; Yang H; Wang H
J Biol Chem; 2014 Nov; 289(47):32883-94. PubMed ID: 25305019
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1.
Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447
[TBL] [Abstract][Full Text] [Related]
13. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
[TBL] [Abstract][Full Text] [Related]
14. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.
Belle JI; Wang H; Fiore A; Petrov JC; Lin YH; Feng CH; Nguyen TTM; Tung J; Campeau PM; Behrends U; Brunet T; Leszinski GS; Gros P; Langlais D; Nijnik A
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641579
[TBL] [Abstract][Full Text] [Related]
15. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency.
Belle JI; Langlais D; Petrov JC; Pardo M; Jones RG; Gros P; Nijnik A
Blood; 2015 Apr; 125(15):2344-8. PubMed ID: 25710881
[TBL] [Abstract][Full Text] [Related]
16. MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway.
Tian M; Liu W; Zhang Q; Huang Y; Li W; Wang W; Zhao P; Huang S; Song Y; Shereen MA; Qin M; Liu Y; Wu K; Wu J
Cell Rep; 2020 Oct; 33(3):108297. PubMed ID: 33086059
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase Mysm1 regulates neural stem cell proliferation and differentiation by controlling Id4 expression.
Xu Z; Qin Q; Wang Y; Zhang H; Liu S; Li X; Chen Y; Wang Y; Ruan H; He W; Zhang T; Yan X; Wang C; Xu D; Jiang X
Cell Death Dis; 2024 Feb; 15(2):129. PubMed ID: 38342917
[TBL] [Abstract][Full Text] [Related]
18. Mysm1 epigenetically regulates the immunomodulatory function of adipose-derived stem cells in part by targeting miR-150.
Wang YH; Huang XH; Yang YM; He Y; Dong XH; Yang HX; Zhang L; Wang Y; Zhou J; Wang C; Jiang XX
J Cell Mol Med; 2019 May; 23(5):3737-3746. PubMed ID: 30895711
[TBL] [Abstract][Full Text] [Related]
19. MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3β signaling impedes castration-resistant prostate cancer growth.
Sun J; Hu X; Gao Y; Tang Q; Zhao Z; Xi W; Yang F; Zhang W; Song Y; Song B; Wang T; Wang H
Aging (Albany NY); 2019 Nov; 11(22):10644-10663. PubMed ID: 31761786
[TBL] [Abstract][Full Text] [Related]
20. MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer.
Luan R; He M; Li H; Bai Y; Wang A; Sun G; Zhou B; Wang M; Wang C; Wang S; Zeng K; Feng J; Lin L; Wei Y; Kato S; Zhang Q; Zhao Y
EMBO Mol Med; 2024 Jan; 16(1):10-39. PubMed ID: 38177530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
